Alpha Cognition Inc
ACOG
NASDAQ
Biotechnology
$8.84
USD
+0.21 (+2.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $192.70M
Volume 247.5K
Revenue
$10.83M
TTM
— YoY
Gross Margin
84%
TTM
— YoY
Net Income
$-25.14M
TTM
— YoY
Operating Cash Flow
$-30.13M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 2.9 | 1.7 | 2.8 | 2.8 | 3.5 |
YoY Growth | — | — | — | — | +20.7% |
Cost of Revenue | 0.8 | 0.5 | 0.6 | 0.3 | 0.3 |
Gross Profit | 2.1 | 1.1 | 2.2 | 2.5 | 3.3 |
Selling, General & Administrative | 5.1 | 6.5 | 6.9 | 9.9 | 10.3 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 5.5 | 6.9 | 7.5 | 10.5 | 11.4 |
Operating Income | -3.4 | -5.7 | -5.3 | -7.9 | -8.1 |
EBITDA | -3.4 | -5.7 | -5.3 | -7.9 | -8.1 |
Other Income / Expense | 1.2 | -5.2 | 3.6 | 0.4 | 1.1 |
Total Other Income / Expense | 1.7 | -4.8 | 4.0 | 1.1 | 1.6 |
Income Before Income Taxes | -1.7 | -10.5 | -1.3 | -6.9 | -6.5 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -1.7 | -10.5 | -1.3 | -6.9 | -6.5 |
Consolidated Net Income / Loss | -1.7 | -10.5 | -1.3 | -6.9 | -6.5 |
Net Income Attributable to Common Shareholders | -1.7 | -10.5 | -1.3 | -6.9 | -6.5 |
Basic EPS | -$0.11 | -$0.65 | -$0.08 | -$0.30 | -$0.30 |
Diluted EPS | -$0.11 | -$0.65 | -$0.30 | -$0.31 | -$0.32 |
Basic Shares Outstanding | 16.0M | 16.0M | 16.1M | 22.5M | 21.8M |
Diluted Shares Outstanding | 16.0M | 16.0M | 16.4M | 22.3M | 21.9M |